Much has been talked about the potentials of AI in drug discovery, time for a reality check!
Join us for a breakfast hosted by Merantix, in collaboration with Cathay Innovation, for an engaging discussion with industry leaders on the advancements and future potential of AI in drug discovery.
Gain first-hand insights from:
🎤 Gregory Vladimer: Co-Founder at Merantix Stealth Venture.
🎤 Costanza Carissimo: Director at Cathay Innovation.
🎤 Nikolaus Krall: EVP Precision Medicine at Exscientia.
🎤 Hervé Minoux: Head of AI for Large Molecule Research at Sanofi.
Following the panel discussion, there will be an opportunity for networking and sharing knowledge over breakfast.
Disclaimer:
By taking part in this event you grant the event organizers and partners full rights to use the images resulting from the photography/video filming, and any reproductions or adaptations of the images for fundraising, publicity or other purposes to help achieve the organizers’ aims. This might include (but is not limited to), the right to use them in their printed and online publicity, social media, press releases and funding applications. You consent to receiving communications from the organizers of the event, keeping you informed about future updates and relevant information. The unauthorized reproduction, distribution or exhibition of the content from the events is prohibited. You agree to abstain from bringing weapons, pets and/or animals to the venue. You agree to adhere to the rules, policies, and security protocols in the facilities. Date and times of the event are subject to change without prior notice.